S. Topuk

发表

Outcomes of aggressive concurrent radiochemotherapy in highly selected septuagenarians with stage IIIB non-small cell lung carcinoma: retrospective analysis of 89 patients.

U. Selek, E. Topkan, O. Guler, 2013, Lung cancer.

Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

E. Topkan, C. Parlak, B. Pehlivan, 2012, BMC Cancer.

Non-small cell lung cancer, locally advanced

P. Lambin, S. Kozlov, I. Petersen, 2012 .

Is it Possible to Expedite Studies on the Effects of Pharmacological Agents on Primary Cell Cultures Obtained from High-grade Fibular Osteosarcoma?

O. Guler, M. Mahiroğulları, S. Akkaya, 2016 .

Systematic Evaluation of Drug-Loaded Hydrogels for Application in Osteosarcoma Treatment.

M. Mahiroğulları, T. Onay, O. Ofluoğlu, 2016, Current pharmaceutical biotechnology.

Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report

C. Onal, N. Bal, E. Topkan, 2009, Clinical medicine. Case reports.

Systematic Evaluation of Promising Clinical Trials-Gene Silencing for the Treatment of Glioblastoma.

N. Karaarslan, I. Yilmaz, H. Ozbek, 2018, Turkish neurosurgery.

Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide

Cem Parlak, E. Topkan, Erkan Topkan, 2012, American journal of clinical oncology.

Comparison of Computed Tomography- and Positron Emission Tomography-Based Radiotherapy Planning in Cholangiocarcinoma

A. Yapar, C. Onal, M. Yavuz, 2013, Oncology Research and Treatment.

Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?

M. Mahiroğulları, S. Akkaya, H. Özbek, 2017, Current pharmaceutical biotechnology.